Impaired lipid metabolism markers to assess the risk of neuroinflammation in autism spectrum disorder
- 22 March 2018
- journal article
- research article
- Published by Springer Nature in Metabolic Brain Disease
- Vol. 33 (4) , 1141-1153
Abstract
Autism spectrum disorder (ASD) is a multifactorial disorder caused by an interaction between environmental risk factors and a genetic background. It is characterized by impairment in communication, social interaction, repetitive behavior, and sensory processing. The etiology of ASD is still not fully understood, and the role of neuroinflammation in autism behaviors needs to be further investigated. The aim of the present study was to test the possible association between prostaglandin E2 (PGE2), cyclooxygenase-2 (COX-2), microsomal prostaglandin E synthase-1 (mPGES-1), prostaglandin PGE2 EP2 receptors and nuclear kappa B (NF-κB) and the severity of cognitive disorders, social impairment, and sensory dysfunction. PGE2, COX-2, mPGES-1, PGE2-EP2 receptors and NF-κB as biochemical parameters related to neuroinflammation were determined in the plasma of 47 Saudi male patients with ASD, categorized as mild to moderate and severe as indicated by the Childhood Autism Rating Scale (CARS) or the Social Responsiveness Scale (SRS) or the Short Sensory Profile (SSP) and compared to 46 neurotypical controls. The data indicated that ASD patients have remarkably higher levels of the measured parameters compared to neurotypical controls, except for EP2 receptors that showed an opposite trend. While the measured parameter did not correlate with the severity of social and cognitive dysfunction, PGE2, COX-2, and mPGES-1 were remarkably associated with the dysfunction in sensory processing. NF-κB was significantly increased in relation to age. Based on the discussed data, the positive correlation between PGE2, COX-2, and mPGES-1 confirm the role of PGE2 pathway and neuroinflammation in the etiology of ASD, and the possibility of using PGE2, COX-2 and mPGES-1 as biomarkers of autism severity. NF-κB as inflammatory inducer showed an elevated level in plasma of ASD individuals. Receiver operating characteristic analysis together with predictiveness diagrams proved that the measured parameters could be used as predictive biomarkers of biochemical correlates to ASD.Keywords
Funding Information
- Female Center for Scientific and Medical Colleges, King Saud University
This publication has 90 references indexed in Scilit:
- Redox metabolism abnormalities in autistic children associated with mitochondrial diseaseTranslational Psychiatry, 2013
- Evidence of oxidative damage and inflammation associated with low glutathione redox status in the autism brainTranslational Psychiatry, 2012
- A review of research trends in physiological abnormalities in autism spectrum disorders: immune dysregulation, inflammation, oxidative stress, mitochondrial dysfunction and environmental toxicant exposuresMolecular Psychiatry, 2011
- Microglial Activation and Chronic NeurodegenerationNeurotherapeutics, 2010
- Impaired cognition, sensorimotor gating, and hippocampal long-term depression in mice lacking the prostaglandin E2 EP2 receptorExperimental Neurology, 2009
- Elevated immune response in the brain of autistic patientsJournal of Neuroimmunology, 2009
- S-nitrosylation/activation of COX-2 mediates NMDA neurotoxicityProceedings of the National Academy of Sciences, 2008
- Prostaglandin receptor EP2 protects dopaminergic neurons against 6-OHDA-mediated low oxidative stressNeuroscience Letters, 2008
- Prostaglandins are necessary and sufficient to induce contextual fear learning impairments after interleukin-1 beta injections into the dorsal hippocampusNeuroscience, 2007
- Aldose reductase regulates TNF-α-induced PGE2 production in human colon cancer cellsCancer Letters, 2007